Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-12

Clinical Trial Update: Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.

View source ↗

Summary

A real-world study in Greek men with benign prostatic hyperplasia assessing disease control and quality of life while treated with a solifenacin/tamsulosin fixe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin/tamsulosin fixed-dose combination (solifenacin; tamsulosin)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Benign Prostatic Hyperplasia | Status: RECRUITING